160 related articles for article (PubMed ID: 7956311)
21. Interleukin-2 immunotherapy and AIDS-related cytomegalovirus retinitis.
Dix RD; Cousins SW
Curr HIV Res; 2004 Oct; 2(4):333-42. PubMed ID: 15544454
[TBL] [Abstract][Full Text] [Related]
22. A Mouse Model That Mimics AIDS-Related Cytomegalovirus Retinitis: Insights into Pathogenesis.
Oh JJ; Carter JJ; Dix RD
Pathogens; 2021 Jul; 10(7):. PubMed ID: 34358000
[TBL] [Abstract][Full Text] [Related]
23. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
24. Decrease of murine cytomegalovirus-induced retinitis by intravenous delivery of immediate early protein-3-specific siRNA.
Marshall B; Mo J; Covar J; Atherton SS; Zhang M
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4151-7. PubMed ID: 24906861
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of ocular and systemic antigen-specific T-cell responses elicited during murine cytomegalovirus retinitis.
Zinkernagel MS; Petitjean C; Wikstrom ME; Degli-Esposti MA
Immunol Cell Biol; 2012 Mar; 90(3):330-6. PubMed ID: 21577228
[TBL] [Abstract][Full Text] [Related]
26. Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue.
Kercher L; Mitchell BM
J Infect Dis; 2000 Sep; 182(3):652-61. PubMed ID: 10950756
[TBL] [Abstract][Full Text] [Related]
27. Immune dysfunction during alcohol consumption and murine AIDS: the protective role of dehydroepiandrosterone sulfate.
Lee J; Sepúlveda RT; Jiang S; Zhang Z; Inserra P; Zhang Y; Hosseini S; Watson RR
Alcohol Clin Exp Res; 1999 May; 23(5):856-62. PubMed ID: 10371406
[TBL] [Abstract][Full Text] [Related]
28. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
Bale JF; O'Neil ME; Folberg R
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis in the retina during MCMV retinitis in immunosuppressed BALB/c mice.
Zhang M; Atherton SS
J Clin Virol; 2002 Aug; 25 Suppl 2():S137-47. PubMed ID: 12361764
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
Green KA; Noelle RJ; Durell BG; Green WR
J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of CD4+ T cells which transfer murine AIDS (MAIDS).
Donaldson LA; Cheng R; Savage SM; Sopori ML
Cell Immunol; 1994 Jul; 156(2):468-79. PubMed ID: 7912998
[TBL] [Abstract][Full Text] [Related]
32. The role of IL-12 in the control of MCMV is fundamentally different in mice with a retroviral immunodeficiency syndrome (MAIDS).
Peacock CD; Price P
Immunol Cell Biol; 1999 Apr; 77(2):131-8. PubMed ID: 10234548
[TBL] [Abstract][Full Text] [Related]
33. Retinitis in euthymic mice following inoculation of murine cytomegalovirus (MCMV) via the supraciliary route.
Atherton SS; Newell CK; Kanter MY; Cousins SW
Curr Eye Res; 1991 Jul; 10(7):667-77. PubMed ID: 1655355
[TBL] [Abstract][Full Text] [Related]
34. Lethal shock is inducible by lipopolysaccharide but not by superantigen in mice with retrovirus-induced immunodeficiency syndrome.
Aoki Y; Hiromatsu K; Arai T; Usami J; Makino M; Ishida H; Yoshikai Y
J Immunol; 1995 Oct; 155(7):3494-500. PubMed ID: 7561044
[TBL] [Abstract][Full Text] [Related]
35. T cell depletion increases susceptibility to murine cytomegalovirus retinitis.
Atherton SS; Newell CK; Kanter MY; Cousins SW
Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3353-60. PubMed ID: 1330968
[TBL] [Abstract][Full Text] [Related]
36. Triple retinal infection with human immunodeficiency virus type 1, cytomegalovirus, and herpes simplex virus type 1. Light and electron microscopy, immunohistochemistry, and in situ hybridization.
Rummelt V; Rummelt C; Jahn G; Wenkel H; Sinzger C; Mayer UM; Naumann GO
Ophthalmology; 1994 Feb; 101(2):270-9. PubMed ID: 8115149
[TBL] [Abstract][Full Text] [Related]
37. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression.
Gao EK; Yu XH; Lin CP; Zhang H; Kaplan HJ
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2322-7. PubMed ID: 7558728
[TBL] [Abstract][Full Text] [Related]
38. Accelerated progression of a murine retrovirus-induced immunodeficiency syndrome in Fas mutant C57BL/6 lpr/lpr mice.
Hiromatsu K; Usami J; Aoki Y; Makino M; Yoshikai Y
Microbiol Immunol; 1997; 41(3):221-7. PubMed ID: 9130234
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic T lymphocytes directed against MAIDS-associated tumors and cells from mice infected by the LP-BM5 MAIDS defective retrovirus.
Green WR; Crassi KM; Schwarz DA; Green KA
Virology; 1994 Apr; 200(1):292-6. PubMed ID: 8128630
[TBL] [Abstract][Full Text] [Related]
40. NK cell modulation of murine cytomegalovirus retinitis.
Bigger JE; Thomas CA; Atherton SS
J Immunol; 1998 Jun; 160(12):5826-31. PubMed ID: 9637493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
